FDA, NIH, CHPA to hold adolescent OTC drug use workshop

As of April 2, 2025, liraglutide remained in shortage, with the drug first entering the FDA database on July 18, 2023.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

The decision makes the therapy the first oral antibiotic treatment approved for uUTIs in over 20 years.

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

The decision makes the RNAi therapeutic the only therapy approved by the FDA to treat ATTR-CM and hATTR-PN.

The new approval is an oral suspension for patients with hypertension and left ventricular hypertrophy and for the treatment of diabetic nephropathy.